Published in EMBO J on October 15, 2001
Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket. Proc Natl Acad Sci U S A (2005) 2.50
Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication. J Cell Biol (2002) 2.28
Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J (2004) 1.94
Heparin-binding domains in vascular biology. Arterioscler Thromb Vasc Biol (2004) 1.71
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (2003) 1.42
Adeno-associated virus-2 and its primary cellular receptor--Cryo-EM structure of a heparin complex. Virology (2009) 1.23
Structural and functional analysis of slit and heparin binding to immunoglobulin-like domains 1 and 2 of Drosophila Robo. J Biol Chem (2008) 1.19
Crystal structure of the OpcA integral membrane adhesin from Neisseria meningitidis. Proc Natl Acad Sci U S A (2002) 1.14
MET: a critical player in tumorigenesis and therapeutic target. Cold Spring Harb Perspect Biol (2013) 1.06
A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. Proc Natl Acad Sci U S A (2007) 1.03
Structural basis for agonism and antagonism of hepatocyte growth factor. Proc Natl Acad Sci U S A (2010) 0.99
Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis. Proc Natl Acad Sci U S A (2010) 0.99
Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell (2012) 0.95
Galactose recognition by the apicomplexan parasite Toxoplasma gondii. J Biol Chem (2012) 0.88
Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists. Proc Natl Acad Sci U S A (2011) 0.87
Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra. Int J Exp Pathol (2015) 0.87
Differential mitogenic effects of single chain hepatocyte growth factor (HGF)/scatter factor and HGF/NK1 following cleavage by factor Xa. J Biol Chem (2002) 0.85
Achieving high signal-to-noise in cell regulatory systems: Spatial organization of multiprotein transmembrane assemblies of FGFR and MET receptors. Prog Biophys Mol Biol (2015) 0.83
Docking server for the identification of heparin binding sites on proteins. J Chem Inf Model (2014) 0.81
An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist. FEBS Lett (2014) 0.78
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals (Basel) (2010) 0.78
BFMP: a method for discretizing and visualizing pyranose conformations. J Chem Inf Model (2014) 0.78
NMR solution structure of the neurotrypsin Kringle domain. Biochemistry (2008) 0.78
Semi-synthesis of a HGF/SF kringle one (K1) domain scaffold generates a potent in vivo MET receptor agonist. Chem Sci (2015) 0.77
Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor. Biochem J (2005) 0.76
Thiocarbamate-linked polysulfonate-peptide conjugates as selective hepatocyte growth factor receptor binders. Bioconjug Chem (2014) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Solvent content of protein crystals. J Mol Biol (1968) 106.07
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Raster3D Version 2.0. A program for photorealistic molecular graphics. Acta Crystallogr D Biol Crystallogr (1994) 17.44
An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model (1997) 11.53
Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell (1991) 8.99
Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (1991) 8.68
Molecular cloning and expression of human hepatocyte growth factor. Nature (1989) 6.91
Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature (1995) 6.13
Scatter factor/hepatocyte growth factor is essential for liver development. Nature (1995) 5.91
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol Cell (2000) 5.72
Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (1991) 5.64
3D domain swapping: a mechanism for oligomer assembly. Protein Sci (1995) 4.96
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature (1995) 4.68
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature (2000) 3.90
Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun (1989) 3.21
Heparin structure and interactions with basic fibroblast growth factor. Science (1996) 3.00
"Diabodies": small bivalent and bispecific antibody fragments. Proc Natl Acad Sci U S A (1993) 2.91
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J (1992) 2.65
Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc Natl Acad Sci U S A (1989) 2.61
Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev (1998) 2.51
Efficient rebuilding of protein structures. Acta Crystallogr D Biol Crystallogr (1996) 2.27
Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem (1992) 2.20
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol (1993) 2.14
Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J Biol Chem (2000) 2.01
Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med (Berl) (1996) 1.91
Conformation and dynamics of heparin and heparan sulfate. Glycobiology (2000) 1.88
Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J Biol Chem (2000) 1.76
Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron (1996) 1.73
Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature (1998) 1.71
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci U S A (1992) 1.70
Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem (1993) 1.57
Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J Biol Chem (1994) 1.52
Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (1991) 1.44
Crystal structure of a diabody, a bivalent antibody fragment. Structure (1994) 1.32
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci (1994) 1.29
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci U S A (2000) 1.25
Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem J (1992) 1.20
Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J Cell Biol (1996) 1.19
Evidence for non-covalent clusters of the c-met proto-oncogene product. Oncogene (1992) 1.16
An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur J Biochem (1991) 1.15
Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem (1995) 1.14
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nat Struct Biol (1999) 1.14
Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem (1996) 1.13
Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem (1994) 1.13
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol (1998) 1.10
The branchial arches and HGF are growth-promoting and chemoattractant for cranial motor axons. Development (2000) 1.08
Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex. Biochemistry (2000) 1.02
Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution. Structure (1998) 1.01
Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. J Biol Chem (1993) 0.98
Crystalline structure of heparin. Adv Exp Med Biol (1975) 0.97
Identification and dynamics of a heparin-binding site in hepatocyte growth factor. Biochemistry (1999) 0.96
Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives. Cancer (2000) 0.95
NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Mol Cell Biol (1998) 0.93
The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site. Structure (1998) 0.92
HGF/SF inhibits junctional communication. Exp Cell Res (1995) 0.81
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J Mol Biol (2001) 10.02
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Scatter factor/hepatocyte growth factor is essential for liver development. Nature (1995) 5.91
HOMSTRAD: a database of protein structure alignments for homologous families. Protein Sci (1998) 5.62
The TRANSPARENT TESTA GLABRA1 locus, which regulates trichome differentiation and anthocyanin biosynthesis in Arabidopsis, encodes a WD40 repeat protein. Plant Cell (1999) 4.54
JOY: protein sequence-structure representation and analysis. Bioinformatics (1998) 4.10
Definition of general topological equivalence in protein structures. A procedure involving comparison of properties and relationships through simulated annealing and dynamic programming. J Mol Biol (1990) 4.02
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Nature (2000) 3.90
Knowledge based modelling of homologous proteins, Part I: Three-dimensional frameworks derived from the simultaneous superposition of multiple structures. Protein Eng (1989) 3.79
The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci (1988) 3.30
A database of globular protein structural domains: clustering of representative family members into similar folds. Fold Des (1996) 3.23
An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues. J Mol Biol (1996) 3.15
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol (1998) 3.05
Knowledge-based prediction of protein structures and the design of novel molecules. Nature (1987) 2.99
Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. J Mol Biol (1989) 2.86
Environment-specific amino acid substitution tables: tertiary templates and prediction of protein folds. Protein Sci (1992) 2.61
A six-stranded double-psi beta barrel is shared by several protein superfamilies. Structure (1999) 2.57
Tertiary structural constraints on protein evolutionary diversity: templates, key residues and structure prediction. Proc Biol Sci (1990) 2.53
New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature (1991) 2.47
Structural evidence for gene duplication in the evolution of the acid proteases. Nature (1978) 2.47
Atomic positions in rhombohedral 2-zinc insulin crystals. Nature (1971) 2.31
X-ray analysis of beta B2-crystallin and evolution of oligomeric lens proteins. Nature (1990) 2.21
Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis. Protein Eng (2000) 2.20
Receptor-binding region of insulin. Nature (1976) 2.14
Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Biol (2001) 2.07
Structure of pentameric human serum amyloid P component. Nature (1994) 2.07
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase. J Mol Biol (1999) 2.00
HOMSTRAD: adding sequence information to structure-based alignments of homologous protein families. Bioinformatics (2001) 1.97
Original and artificial antibodies. Nature (1992) 1.97
Alignment and searching for common protein folds using a data bank of structural templates. J Mol Biol (1993) 1.97
Crystal structure of aspartate decarboxylase at 2.2 A resolution provides evidence for an ester in protein self-processing. Nat Struct Biol (1998) 1.89
Comparison of solvent-inaccessible cores of homologous proteins: definitions useful for protein modelling. Protein Eng (1987) 1.81
Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol (1995) 1.79
Hepatocytes and scatter factor. Nature (1990) 1.77
Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid (2005) 1.76
Hormone families: pancreatic hormones and homologous growth factors. Nature (1980) 1.71
Prediction of the stability of protein mutants based on structural environment-dependent amino acid substitution and propensity tables. Protein Eng (1997) 1.69
Knowledge-based protein modeling. Crit Rev Biochem Mol Biol (1994) 1.65
Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell (1992) 1.62
Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature (1998) 1.61
Fragment ranking in modelling of protein structure. Conformationally constrained environmental amino acid substitution tables. J Mol Biol (1993) 1.60
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem (1999) 1.58
Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. Protein Eng (1989) 1.58
Epidermal growth factor binding induces a conformational change in the external domain of its receptor. EMBO J (1989) 1.56
Modeling alpha-helical transmembrane domains: the calculation and use of substitution tables for lipid-facing residues. Protein Sci (1993) 1.53
Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta (1991) 1.53
CODA: a combined algorithm for predicting the structurally variable regions of protein models. Protein Sci (2001) 1.53
X-ray analyses of aspartic proteinases. II. Three-dimensional structure of the hexagonal crystal form of porcine pepsin at 2.3 A resolution. J Mol Biol (1990) 1.52
A variable gap penalty function and feature weights for protein 3-D structure comparisons. Protein Eng (1992) 1.51
Structure of porphobilinogen deaminase reveals a flexible multidomain polymerase with a single catalytic site. Nature (1992) 1.48
Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol (1999) 1.42
High resolution structure of an oligomeric eye lens beta-crystallin. Loops, arches, linkers and interfaces in beta B2 dimer compared to a monomeric gamma-crystallin. J Mol Biol (1991) 1.40
Is the evolution of insulin Darwinian or due to selectively neutral mutation? Nature (1975) 1.38
From comparisons of protein sequences and structures to protein modelling and design. Trends Biochem Sci (1990) 1.37
Molecular recognition in protein families: a database of aligned three-dimensional structures of related proteins. Biochem Soc Trans (1993) 1.37
Cloning of mouse ptx3, a new member of the pentraxin gene family expressed at extrahepatic sites. Blood (1996) 1.37
Mutation and selection during the secondary response to 2-phenyloxazolone. Proc Natl Acad Sci U S A (1991) 1.35
CAMPASS: a database of structurally aligned protein superfamilies. Structure (1998) 1.33
Insulin-like growth factor: a model for tertiary structure accounting for immunoreactivity and receptor binding. Proc Natl Acad Sci U S A (1978) 1.32
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci (1994) 1.29
Epithelial scatter factor and development of the chick embryonic axis. Development (1990) 1.28
Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid (2004) 1.28
Fibroblast growth factor receptors: lessons from the genes. Trends Biochem Sci (1998) 1.26
The structural repertoire of the human V kappa domain. EMBO J (1995) 1.26
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation. Development (1995) 1.25
High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes. Nature (1987) 1.25
Getting knotted: a model for the structure and activation of Spätzle. Trends Biochem Sci (1998) 1.24
A novel superfamily of enzymes that catalyze the modification of guanidino groups. Trends Biochem Sci (2001) 1.24
An automatic method involving cluster analysis of secondary structures for the identification of domains in proteins. Protein Sci (1995) 1.23
Crystal structure analysis of deamino-oxytocin: conformational flexibility and receptor binding. Science (1986) 1.22
Conformational analysis and clustering of short and medium size loops connecting regular secondary structures: a database for modeling and prediction. Protein Sci (1996) 1.22
Incorporating knowledge-based biases into an energy-based side-chain modeling method: application to comparative modeling of protein structure. Biopolymers (2001) 1.22
Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography. J Mol Biol (2000) 1.21
The relation of conformation and association of insulin to receptor binding; x-ray and circular-dichroism studies on bovine and hystricomorph insulins. Eur J Biochem (1975) 1.21
Properties of polyproline II, a secondary structure element implicated in protein-protein interactions. Proteins (2005) 1.20
Characterization of inositol 1,4,5-trisphosphate- and inositol 1,3,4,5-tetrakisphosphate-binding sites in rat cerebellum. Biochem J (1991) 1.20
Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases. Protein Sci (1992) 1.20
Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J Biol Chem (1994) 1.20
Structural variation in mammalian gamma-crystallins based on computer graphics analyses of human, rat and calf sequences. 1. Core packing and surface properties. Exp Eye Res (1986) 1.20
Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors. Structure (1993) 1.20
A disaccharide repeat unit is the major structure in fucoidans from two species of brown algae. Carbohydr Res (2001) 1.19
Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action. J Biol Chem (1996) 1.18
Structure and anticoagulant activity of sulfated fucans. Comparison between the regular, repetitive, and linear fucans from echinoderms with the more heterogeneous and branched polymers from brown algae. J Biol Chem (1999) 1.18
Sequence-structure homology recognition by iterative alignment refinement and comparative modeling. Proteins (2001) 1.17
An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure. Protein Eng (1993) 1.17
Carbonyl-carbonyl interactions stabilize the partially allowed Ramachandran conformations of asparagine and aspartic acid. Protein Eng (1999) 1.17
X-ray analysis and the structure of insulin. Recent Prog Horm Res (1971) 1.16
Non-random features of the repertoire expressed by the members of one V kappa gene family and of the V-J recombination. Eur J Immunol (1992) 1.15
Domain flexibility in aspartic proteinases. Proteins (1992) 1.15
Structure of a fucose-branched chondroitin sulfate from sea cucumber. Evidence for the presence of 3-O-sulfo-beta-D-glucuronosyl residues. J Biol Chem (1991) 1.14
Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding. Nat Struct Biol (1999) 1.14